A PBM audit that opens as a routine documentation review often narrows, within a handful of claims, to one question: did the pharmacy actually collect the copay it billed. A copay collection finding arises when the amount the pharmacy reported on the claim does not match what the patient actually paid, and PBM audit teams treat that gap as evidence the pharmacy billed the plan for more than it charged the patient. What separates a defensible finding from a serious one is documentation, and, when a government-funded plan is involved, the pattern behind it.
How Auditors Test Copay Collection
PBM audit teams do not take the copay field on an adjudicated claim at face value. They compare it against point-of-sale receipts, a signed patient log confirming the amount collected, and the pharmacy's internal ledger showing the payment cleared. Some audits go further and directly contact the patient to ask what they remember paying, then measure that answer against the pharmacy's own records. A pharmacy that can produce only the claim itself, with no independent payment record behind it, or whose records conflict with what the patient tells the auditor, gets the discrepancy flagged as a finding regardless of intent.
Documented Hardship Waivers Versus Routine Waiver Patterns
Most PBM manuals permit a pharmacy to waive or reduce a specific patient's copay when the pharmacy makes an individualized determination that paying it in full would create a genuine financial hardship, and documents that determination in the patient's file at the time. A documented bad-debt write-off, made after a real and recorded collection attempt failed, holds up the same way on audit and on audit appeal, because the file shows the pharmacy tried to collect and made a specific judgment call for that patient. A different pattern draws far more scrutiny: a pharmacy that waives the same drug's copay for most patients who fill it, with no individualized hardship note for any of them. Auditors read that as routine discounting, not hardship, and it leaves an appeal with no individualized record to point to.
When a Waiver Pattern Touches a Government-Funded Plan
The exposure changes when the claims inside a routine waiver pattern are billed to Medicare, Medicaid, or another government-funded plan. Waiving a beneficiary's cost-sharing obligation as a matter of course, rather than through individualized hardship determinations made and documented case by case, can be read by regulators as more than a billing discrepancy. A pattern like that can look like an inducement, a way of using the waiver to steer government-insured patients toward the pharmacy or a particular drug, and that reading moves the matter into the kind of question federal and state fraud enforcement takes seriously. A pharmacy defending a routine waiver pattern on a government-funded plan is no longer only answering an audit finding.
What a Copay Finding Can Trigger
A sustained copay collection finding rarely stays contained to the flagged claims. PBMs typically apply the discrepancy rate found in the sample across the full lookback period, turning a handful of unproven claims into a recoupment demand covering years of dispensing. A pattern the PBM reads as habitual, rather than isolated, also supports network termination, and PBM provider manuals often treat copay non-collection as a termination-for-cause basis on its own, independent of any recoupment outcome. From Audit Finding to Network Termination: How PBMs Escalate walks through how a single finding like this compounds into a termination decision.
A documented, individualized hardship waiver defends a pharmacy on audit. A routine waiver pattern defends nothing, and on a government-funded plan it invites a fraud inquiry the pharmacy never intended to start.
Why Early Legal Counsel Is Critical
It is critical that pharmacies retain experienced healthcare defense counsel promptly upon receiving a PBM audit notice that flags copay collection, particularly where the underlying pattern touches Medicare, Medicaid, or another government-funded plan. Early legal intervention can protect the pharmacy's rights, ensure the response accurately documents the individualized hardship determinations already on file, avoid characterizations that turn a documentation gap into an admission, and preserve the pharmacy's position for appeal. Delaying legal representation can significantly affect the outcome of the audit and expose the pharmacy to recoupment, network termination, or a referral neither the pharmacy nor its patients anticipated.
How Health Law Alliance Can Help
Health Law Alliance has represented 2,500+ clients over 25+ years, including pharmacies facing PBM audits that turn on copay collection and waiver documentation. Our PBM audit defense attorneys build the record that distinguishes a defensible hardship waiver from a pattern a PBM reads as routine, respond to extrapolated recoupment demands, and represent pharmacies through appeal and, where a government-funded plan is involved, through the inquiries that can follow. Contact Health Law Alliance for a free, confidential consultation.
